Jawad Ahmad, MD
img_Jawad Ahmad
PROFESSOR | Medicine, Liver Diseases
Are you a patient?
Specialties
Liver Transplantation
Research Topics
Liver, Transplantation
Dr Jawad Ahmad is co Primary Investigator on NIH/NIDDK research initiative to study cases of severe liver injury caused by caused by prescription drugs, over-the-counter drugs, and alternative medicines, such as herbal products and supplements.  For more information  on the Drug-Induced Liver Injury Network (DILIN) visit: https://dilin.dcri.duke.edu/

MD, Royal Free Hospital School of Medicine

Residency, Internal Medicine, Renaissance School of Medicine at Stony Brook University

Fellowship, Transplant Hepatology, University of Pittsburgh Medical Center

Publications

Selected Publications

Clinical practice of indocyanine green fluorescence imaging in robotic liver surgery – a global expert survey. Noa L.E. Aegerter, Christoph Kuemmerli, Adrian T. Billeter, Caroline Berchtold, Felix Nickel, Cristiano Guidetti, Taiga Wakabayashi, Iswanto Sucandy, Brian K. Goh, Mathieu D’Hondt, Hugo Pinto Marques, Janina Eden, Philipp Dutkowski, Jason Hawksworth, Patrick Starlinger, Beat P. Müller, Philip C. Müller, Roeland F. de Wilde, Christoph Tschuor, Stéphanie Truant, Roberto Ivan Troisi, Christian Toso, Samer Tohme, Yu Takahashi, Rutger Jan Swijnenburg, Benjamin Struecker, Stefan Stättner, Gregor Stavrou, Jimin Son, Daniel Seehofer, Moritz Schmelzle, Olivier Saint-Marc, Andrea Ruzzenente, Ricardo Robles-Campos, Christoph Reissfelder, Francesca Ratti, Nuh Rahbari, Florian Primavesi, Fabrizio Panaro, Atsushi Oba, Yusuke Nie, Yutaka Nakano, Zenichi Morise, Takuya Minagawa, John B. Martinie, Charles Chung Wei Lin, Mickael Lesurtel, Yoshikuni Kawaguchi, Philipp Kron, Jawad Ahmad. Surgical Endoscopy

Learnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management. Perry B. Shieh, Crystal Proud, Tamir Diamond, Catherine A. Chapin, Jawad Ahmad, Alan D. Salama, Carsten G. Bönnemann, Jonathan Soslow, Barry J. Byrne, Aravindhan Veerapandiyan, John F. Brandsema, Susan Matesanz, Benjamin J. Samelson-Jones, Benjamin J. Wilkins, Marianne Gerber, Kara E. Godwin Wild, Stefanie Mason, Damon Asher, Craig M. McDonald, Jerry R. Mendell. Human Gene Therapy

Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network. Jawad Ahmad, Andrew Dellinger, Paola Nicoletti, Huiman X. Barnhart, Marwan Ghabril, Robert J. Fontana, Victor Navarro, Gina Choi, Paul H. Hayashi, Jiezhun Gu, David Kleiner. American Journal of Gastroenterology

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Ahmad has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.